Famotidine, an Antiulcer Agent, Strongly InhibitsHelicobacter pyloriand Human Carbonic Anhydrases.
Angeli, A., Ferraroni, M., Supuran, C.T.(2018) ACS Med Chem Lett 9: 1035-1038
- PubMed: 30344913 
- DOI: https://doi.org/10.1021/acsmedchemlett.8b00334
- Primary Citation of Related Structures:  
6G3Q, 6G3V - PubMed Abstract: 
Famotidine, an antiulcer drug incorporating a sulfamide motif, was investigated as carbonic anhydrase inhibitor (CAI). It acts as a nanomolar inhibitor of several human (hCA II, VI, VII and XII) and Helicobacter pylori CAs. The high resolution X-ray structures of famotidine bound to hCA I and II revealed interesting aspects related to its CA inhibition mechanism, offering the possibility to develop antibacterials with a novel mechanism of action.
Organizational Affiliation: 
University of Florence, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.